1st Global Consensus for Clinical Guidelines: Identifying a Core Outcome Set for Implant Dentistry in Edentulous Maxilla Rehabilitation

Objectives: To identify a core outcome set (COS) to standardize outcome measures for studies on the rehabilitation of the edentulous maxilla in implant dentistry. This work was conducted in preparation for the 1st Global Consensus for Clinical Guidelines (GCCG) for the Rehabilitation of the Edentulous Maxilla.

Materials and methods: The COS was developed using a standardized and validated methodology, following the Core Outcome Measures in Effectiveness Trials (COMET) initiative. Outcomes were first identified through eight systematic reviews covering surgical and prosthetic aspects of edentulous maxilla rehabilitation. This preliminary list was expanded by input from clinical and cross-disciplinary experts as well as patient surveys to capture additional relevant outcomes that were not represented in the literature. A 3-round Delphi survey was conducted. The first round was conducted prior to the meeting and the second and third round took place during the in-person consensus meeting. In the first round, participants could propose new outcomes and rated each item using a 9-point Likert scale, from 1 (not important) to 9 (critical), with scores of 7-9 denoting critical importance, 4-6 importance, and 1-3 low importance for decision making. In the second round, participants re-scored a revised outcome list incorporating written suggestions and consolidated overlapping items from the first round. Outcomes rated 7-9 by at least 75% of participants in the second round constituted the final COS selection. In the third round, these selected outcomes were evaluated for their relevance across the different stages of the GCCG workflow: patient selection, diagnostic tools, treatment planning, treatment procedure, management of complications during the treatment procedure, maintenance, and management of complications during maintenance.

Results: Of the 105 experts invited, response rates for the three Delphi rounds were 87.6%, 95.2%, and 92.4%, respectively. An initial list of 119 outcomes was generated from systematic reviews and surveys and subsequently refined after the first round based on participant feedback. In the second round, 34 outcomes were rated as critical and included in the final COS. These comprised 10 patient-reported outcomes (PROs): aesthetic satisfaction; chewing function/comfort/discomfort; complications during treatment/maintenance; ease of cleaning/oral hygiene efficacy; pain; patient overall satisfaction with treatment; patient-reported complaints; prosthesis retention/stability; quality of life; speech/phonetics/pronunciation function, 22 objective clinician-reported outcomes (ClinROs): biological complications; history of patient compliance; implant failure; implant primary stability; implant success; implant survival; mechanical/technical complications; peri-implant health (implant level); peri-implant health (patient level); peri-implant mucositis; peri-implant suppuration; peri-implantitis; plaque index/oral hygiene; postoperative complications; presence of keratinized mucosa; prosthesis failure; prosthesis success; prosthetic complications; radiographic marginal bone level; radiographic marginal bone loss; surgical/intraoperative complications; width of keratinized mucosa and two subjective ClinROs (clinician's treatment success; prosthodontic maintenance events/complications). Additional outcomes proposed during the second round were excluded since they represented general comments, process indicators, or alternative wording of outcomes already considered. In the third round, 21 COS outcomes were deemed relevant to the maintenance and/or post-treatment complication management phases, 3 were deemed relevant before treatment, and another 3 were deemed relevant only during treatment.

Conclusion: The proposed COS for studies on the rehabilitation of the edentulous maxilla in implant dentistry was developed using the COMET methodology. Although patients' perspectives were incorporated during the preliminary survey phase, they did not participate directly in the Delphi, highlighting an opportunity for future research to further enhance patient involvement in COS development. The widespread implementation of this COS is expected to improve the consistency of outcome reporting and facilitate comparisons of the effectiveness of current and emerging interventions.

Contributors

Giulia Brunello, Guo-Hao Lin, Ina Kopp, Alonso Carrasco-Labra, Ronald E Jung, Hom-Lay Wang, Frank Schwarz, Franz J Strauss

Publication

Journal: Clin Oral Implants Res
Volume: 37
Issue: Suppl 30
Pages: S108 - S120
Year: 2026
DOI: 10.1111/clr.70075

Further Study Information

Current Stage: Completed
Date: May 2025 - September 2025
Funding source(s): Osteology Foundation (OF) European Association for Osseointegration (EAO) International Team for Implantology (ITI)


Health Area

Disease Category: Dentistry & oral health

Disease Name: Maxillary Edentulism

Target Population

Age Range: 19 - 100

Sex: Either

Nature of Intervention: Dental implant, Surgery

Stakeholders Involved

- Clinical experts
- Conference participants
- Consumers (patients)
- Device manufacturers
- Journal editors
- Methodologists
- Researchers
- Statisticians

Study Type

- COS for clinical trials or clinical research
- COS for practice

Method(s)

- Consensus conference
- Consensus meeting
- Delphi process
- Literature review
- Nominal group technique (NGT)
- Semi structured discussion
- Survey
- Systematic review

The COS was identified using a standardized and validated methodology, following the Core Outcome Measures in Effectiveness Trials (COMET) initiative. Outcomes were identified from eight systematic reviews covering surgical and prosthetic aspects of edentulous maxilla rehabilitation. This generated list was then expanded to include outcomes that were present in expert, as well as cross-disciplinary expert/patient surveys conducted in preparation to the GCCG. Outcomes were rated using a 9-point Likert scale, from 1 (not important) to 9 (critical), with scores of 7–9 denoting critical importance, 4–6 importance, and 1–3 low importance for decision making. The list was refined and additional outcomes from first round were incorporated. Outcomes rated 7–9 by at least 75% of participants in the second round constituted the final COS selection. These were then evaluated in a third round to determine their relevance at different stages of the GCCG workflow (i.e., patient selection; diagnostic tools; treatment planning; treatment procedure; management of complications during treatment procedure; maintenance; management of complications during maintenance).

Linked Studies

    No related studies


Related Links

    No related links